Cormorant Asset Management as of Sept. 30, 2022
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 73 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prometheus Biosciences | 8.2 | $117M | 2.0M | 59.01 | |
Apellis Pharmaceuticals (APLS) | 7.1 | $101M | 1.5M | 68.30 | |
Design Therapeutics (DSGN) | 5.8 | $84M | 5.0M | 16.72 | |
Erasca (ERAS) | 5.7 | $82M | 11M | 7.80 | |
Arcellx Common Stock (ACLX) | 4.0 | $57M | 3.0M | 18.77 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 3.3 | $47M | 6.1M | 7.76 | |
Altimmune Com New (ALT) | 3.1 | $44M | 3.4M | 12.77 | |
Mirati Therapeutics | 2.8 | $40M | 575k | 69.84 | |
Revolution Medicines (RVMD) | 2.7 | $39M | 2.0M | 19.72 | |
Aerovate Therapeutics (AVTE) | 2.7 | $39M | 2.3M | 16.58 | |
Gossamer Bio (GOSS) | 2.7 | $38M | 3.2M | 11.98 | |
Tarsus Pharmaceuticals (TARS) | 2.4 | $34M | 2.0M | 17.12 | |
Karuna Therapeutics Ord | 2.4 | $34M | 150k | 224.93 | |
Avidity Biosciences Ord (RNA) | 2.3 | $33M | 2.0M | 16.33 | |
Immuneering Corp Class A Com (IMRX) | 2.3 | $33M | 2.3M | 14.32 | |
Biomea Fusion (BMEA) | 2.2 | $31M | 3.2M | 9.78 | |
Edgewise Therapeutics (EWTX) | 2.1 | $30M | 3.1M | 9.84 | |
Biohaven Pharmaceutical Holding | 2.0 | $28M | 185k | 151.17 | |
Ventyx Biosciences (VTYX) | 1.9 | $27M | 781k | 34.91 | |
Miragen Therapeutics (VRDN) | 1.9 | $27M | 1.3M | 20.51 | |
Monte Rosa Therapeutics (GLUE) | 1.7 | $25M | 3.0M | 8.17 | |
Greenlight Biosciencs Hlds P Common Stock | 1.7 | $24M | 10M | 2.32 | |
Axonics Modulation Technolog (AXNX) | 1.6 | $23M | 322k | 70.44 | |
Sarepta Therapeutics (SRPT) | 1.5 | $22M | 200k | 110.54 | |
Cogent Biosciences (COGT) | 1.5 | $22M | 1.5M | 14.92 | |
Verve Therapeutics (VERV) | 1.4 | $21M | 600k | 34.35 | |
Adicet Bio (ACET) | 1.4 | $20M | 1.4M | 14.22 | |
Arcutis Biotherapeutics (ARQT) | 1.3 | $19M | 1.0M | 19.11 | |
Amylyx Pharmaceuticals (AMLX) | 1.2 | $17M | 610k | 28.15 | |
Bioatla (BCAB) | 1.2 | $17M | 2.2M | 7.70 | |
Pliant Therapeutics (PLRX) | 1.1 | $16M | 783k | 20.89 | |
Vectivbio Hldg Ord Shs | 1.1 | $15M | 2.5M | 6.00 | |
Tango Therapeutics (TNGX) | 1.0 | $15M | 4.1M | 3.62 | |
Bridgebio Pharma (BBIO) | 1.0 | $15M | 1.5M | 9.94 | |
Cytokinetics Com New (CYTK) | 1.0 | $14M | 296k | 48.45 | |
Stoke Therapeutics (STOK) | 1.0 | $14M | 1.1M | 12.84 | |
Rocket Pharmaceuticals (RCKT) | 1.0 | $14M | 869k | 15.96 | |
Rain Therapeutics | 0.8 | $11M | 2.3M | 4.88 | |
Astria Therapeutics (ATXS) | 0.8 | $11M | 1.2M | 9.04 | |
Eli Lilly & Co. (LLY) | 0.7 | $9.7M | 30k | 323.37 | |
Pharvaris N V (PHVS) | 0.6 | $9.3M | 1.2M | 7.67 | |
Iveric Bio Put Option | 0.6 | $9.0M | 500k | 17.94 | |
Atea Pharmaceuticals (AVIR) | 0.6 | $8.8M | 1.5M | 5.69 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $7.9M | 2.0M | 4.02 | |
Longboard Pharmaceuticals In (LBPH) | 0.6 | $7.9M | 2.1M | 3.72 | |
Gh Research Ordinary Shares (GHRS) | 0.5 | $6.9M | 593k | 11.62 | |
Alx Oncology Hldgs (ALXO) | 0.5 | $6.8M | 712k | 9.57 | |
Tyra Biosciences (TYRA) | 0.5 | $6.5M | 744k | 8.79 | |
Poseida Therapeutics I (PSTX) | 0.5 | $6.5M | 1.9M | 3.53 | |
Ideaya Biosciences (IDYA) | 0.4 | $6.2M | 418k | 14.92 | |
Olema Pharmaceuticals (OLMA) | 0.4 | $5.7M | 2.1M | 2.76 | |
Vigil Neuroscience (VIGL) | 0.4 | $5.6M | 617k | 9.10 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $5.2M | 50k | 103.26 | |
Keros Therapeutics (KROS) | 0.3 | $3.8M | 100k | 37.62 | |
Eledon Pharmaceuticals (ELDN) | 0.2 | $3.4M | 1.2M | 2.76 | |
Akouos | 0.2 | $2.7M | 395k | 6.76 | |
Ambrx Biopharma Sponsored Ads | 0.2 | $2.5M | 2.3M | 1.08 | |
Talaris Therapeutics | 0.2 | $2.4M | 901k | 2.63 | |
Elevation Oncology (ELEV) | 0.2 | $2.2M | 2.0M | 1.13 | |
Y Mabs Therapeutics (YMAB) | 0.2 | $2.2M | 150k | 14.42 | |
Icosavax | 0.1 | $2.0M | 644k | 3.16 | |
Galecto (GLTO) | 0.1 | $1.9M | 1.0M | 1.89 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $1.4M | 831k | 1.71 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $1.3M | 669k | 1.97 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $839k | 392k | 2.14 | |
Cabaletta Bio (CABA) | 0.1 | $750k | 1.2M | 0.65 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $718k | 288k | 2.49 | |
Gelesis Holdings (GLSH) | 0.0 | $676k | 626k | 1.08 | |
Graphite Bio | 0.0 | $633k | 200k | 3.17 | |
Harpoon Therapeutics | 0.0 | $524k | 541k | 0.97 | |
Atreca Cl A Com (BCEL) | 0.0 | $501k | 319k | 1.57 | |
Orchard Therapeutics Spon Ads | 0.0 | $128k | 257k | 0.50 | |
Imv | 0.0 | $122k | 234k | 0.52 |